Bio Medica Laboratories Limited (NSE:BMLL)
India · Delayed Price · Currency is INR 141.45
+2.75 (1.98%)
At close: Jul 27, 2026
Bio Medica Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.04 | 0.07 | 0.1 | 0.06 | 15.28 |
Cash & Short-Term Investments | 1.04 | 0.07 | 0.1 | 0.06 | 15.28 |
Cash Growth | 1422.06% | -34.13% | 68.20% | -99.60% | 4063.83% |
Accounts Receivable | 108.53 | 41 | 23.36 | 40.73 | 54.47 |
Other Receivables | - | - | 0.4 | - | - |
Receivables | 158.71 | 41 | 23.76 | 40.73 | 57.58 |
Inventory | 363.68 | 181.38 | 73.67 | 39.02 | 23.28 |
Prepaid Expenses | - | 0.34 | - | - | - |
Other Current Assets | 23.24 | 88.12 | 6.75 | 9.03 | 6.35 |
Total Current Assets | 546.66 | 310.91 | 104.29 | 88.84 | 102.49 |
Property, Plant & Equipment | 104.91 | 74.61 | 87.27 | 83.11 | 70.99 |
Goodwill | 67.14 | - | - | - | - |
Long-Term Deferred Tax Assets | 3.32 | 2.17 | 1.08 | 0.26 | 0.28 |
Other Long-Term Assets | 2.11 | 3.49 | 1.31 | 3.19 | 0.79 |
Total Assets | 733.08 | 391.18 | 193.95 | 175.4 | 174.55 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 55.72 | 42.78 | 21.59 | 47.98 | 36.16 |
Accrued Expenses | - | 9.47 | 2.92 | 1.6 | - |
Short-Term Debt | 84.33 | 63.56 | 17.33 | 37.33 | 68.41 |
Current Portion of Long-Term Debt | - | 18.94 | 9.91 | 12.03 | - |
Current Income Taxes Payable | - | 34.52 | 10.22 | 1.26 | 2.11 |
Other Current Liabilities | 51.77 | 0.69 | 0.87 | 1.37 | 3.14 |
Total Current Liabilities | 191.82 | 169.94 | 62.85 | 101.57 | 109.81 |
Long-Term Debt | 315.56 | 67.65 | 77.66 | 46.7 | 41.2 |
Pension & Post-Retirement Benefits | - | 3.16 | - | - | - |
Other Long-Term Liabilities | 22.31 | 3.1 | 0 | 0 | - |
Total Liabilities | 529.69 | 243.85 | 140.5 | 148.27 | 151.01 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 91.8 | 91.8 | 1 | 1 | 1 |
Retained Earnings | - | 55.53 | 52.45 | 26.13 | 22.54 |
Comprehensive Income & Other | 173.34 | - | - | - | - |
Total Common Equity | 265.14 | 147.33 | 53.45 | 27.13 | 23.54 |
Minority Interest | -61.74 | - | - | - | - |
Shareholders' Equity | 203.4 | 147.33 | 53.45 | 27.13 | 23.54 |
Total Liabilities & Equity | 733.08 | 391.18 | 193.95 | 175.4 | 174.55 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 399.89 | 150.14 | 104.9 | 96.07 | 109.6 |
Net Cash (Debt) | -398.86 | -150.08 | -104.8 | -96.01 | -94.32 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -43.84 | -16.35 | -11.42 | -10.46 | -10.27 |
Filing Date Shares Outstanding | - | 9.18 | 9.18 | 9.18 | 9.18 |
Total Common Shares Outstanding | - | 9.18 | 9.18 | 9.18 | 9.18 |
Working Capital | 354.84 | 140.97 | 41.44 | -12.73 | -7.32 |
Book Value Per Share | - | 16.05 | 5.82 | 2.96 | 2.56 |
Tangible Book Value | 198 | 147.33 | 53.45 | 27.13 | 23.54 |
Tangible Book Value Per Share | - | 16.05 | 5.82 | 2.96 | 2.56 |
Land | - | 56.57 | 55.19 | 47.78 | - |
Machinery | - | 56.49 | 62.46 | 54.61 | - |